Fosbøl MØ - Search Results

1

Rubidium-82 uptake in metastases from neuroendocrine tumors: No flow response to adenosine.

Hasbak P, Enevoldsen LH, Fosbøl MØ, Skovgaard D, Knigge UP, Kjær A. Hasbak P, et al. Among authors: fosbol mo. J Nucl Cardiol. 2016 Aug;23(4):840-2. doi: 10.1007/s12350-015-0251-z. Epub 2015 Sep 10. J Nucl Cardiol. 2016. PMID: 26358083 No abstract available.

2

²²³Ra Therapy of Advanced Metastatic Castration-Resistant Prostate Cancer: Quantitative Assessment of Skeletal Tumor Burden for Prognostication of Clinical Outcome and Hematologic Toxicity.

Fosbøl MØ, Petersen PM, Kjaer A, Mortensen J. Fosbøl MØ, et al. J Nucl Med. 2018 Apr;59(4):596-602. doi: 10.2967/jnumed.117.195677. Epub 2017 Sep 1. J Nucl Med. 2018. PMID: 28864632 Free article.

3

Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients.

Fosbøl MØ, Petersen PM, Daugaard G, Holm S, Kjaer A, Mortensen J. Fosbøl MØ, et al. Ann Nucl Med. 2018 Jan;32(1):16-21. doi: 10.1007/s12149-017-1212-1. Epub 2017 Oct 3. Ann Nucl Med. 2018. PMID: 28975586

4

An Uncommon Case of Pediatric Esthesioneuroblastoma Presenting as SIADH: ¹⁸F-FDG PET/CT in Staging and Post-Therapeutic Assessment.

Fosbøl MØ, Bilde A, Friborg J, von Benzon E, Kjær A, von Buchwald C, Borgwardt L. Fosbøl MØ, et al. Diagnostics (Basel). 2018 Jan 14;8(1):8. doi: 10.3390/diagnostics8010008. Diagnostics (Basel). 2018. PMID: 29342907 Free PMC article.

5

Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial.

Fosbøl MØ, Kurbegovic S, Johannesen HH, Røder MA, Hansen AE, Mortensen J, Loft A, Petersen PM, Madsen J, Brasso K, Kjaer A. Fosbøl MØ, et al. J Nucl Med. 2021 Mar;62(3):354-359. doi: 10.2967/jnumed.120.248120. Epub 2020 Aug 6. J Nucl Med. 2021. PMID: 32764119 Free PMC article. Clinical Trial.

6

uPAR PET/CT for Prognostication and Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing Radium-223 Therapy: A Prospective Phase II Study.

Fosbøl MØ, Mortensen J, Petersen PM, Loft A, Madsen J, Kjaer A. Fosbøl MØ, et al. Diagnostics (Basel). 2021 Jun 14;11(6):1087. doi: 10.3390/diagnostics11061087. Diagnostics (Basel). 2021. PMID: 34198666 Free PMC article.

7

Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients.

Risør LM, Binderup T, Fosbøl MØ, Andersen KF, Loft A, Friborg J, Kjaer A. Risør LM, et al. Among authors: fosbol mo. Sci Rep. 2022 Nov 9;12(1):19126. doi: 10.1038/s41598-022-21175-7. Sci Rep. 2022. PMID: 36352036 Free PMC article.

8

Author Correction: Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients.

Risør LM, Binderup T, Fosbøl MØ, Andersen KF, Loft A, Friborg J, Kjaer A. Risør LM, et al. Among authors: fosbol mo. Sci Rep. 2023 Jan 24;13(1):1346. doi: 10.1038/s41598-023-28618-9. Sci Rep. 2023. PMID: 36693915 Free PMC article. No abstract available.

9

[¹⁸F]mFBG long axial field of view PET-CT without general anaesthesia reveals concise extension of neuroblastoma in a 9-month-old boy.

Borgwardt L, Brok JS, Andersen KF, Madsen J, Gillings N, Fosbøl MØ, Denholt CL, Wehner PS, Enevoldsen LH, Oturai P, Czyzewska D, Johannesen HH, Højgaard L, Petersen IN, Sørensen LS, Schulze C, Saxtoft ES, Andersen FL, Fischer BM. Borgwardt L, et al. Among authors: fosbol mo. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2563-2564. doi: 10.1007/s00259-023-06160-0. Epub 2023 Feb 28. Eur J Nucl Med Mol Imaging. 2023. PMID: 36849749 Free PMC article. No abstract available.

10

Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study.

van Koningsbruggen-Rietschel S, Davies JC, Pressler T, Fischer R, MacGregor G, Donaldson SH, Smerud K, Meland N, Mortensen J, Fosbøl MØ, Downey DG, Myrset AH, Flaten H, Rye PD. van Koningsbruggen-Rietschel S, et al. Among authors: fosbol mo. ERJ Open Res. 2020 Oct 19;6(4):00132-2020. doi: 10.1183/23120541.00132-2020. eCollection 2020 Oct. ERJ Open Res. 2020. PMID: 33123558 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page